Diagnosing and Treating Immune Thrombocytopenic Purpura
The group continues their analysis of emergencies by exploring their first hematologic emergency: Immune thrombocytopenic purpura (ITP). They explain how to confirm that the diagnosis is in fact ITP, and subsequently, provide a treatment plan.
Genetic Classification Model Differentiates MDS Stem, Progenitor Cells from Healthy Bone Marrow
FDA Grants Breakthrough Therapy Designation to Sacituzumab Govitecan for Second-Line Treatment of ES-SCLC
Genetic Study Uncovers Potential Therapy-Actionable Transcription Factors in MDS